Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Ciprofloxacin 750 mg in Healthy Adults
NCT05532267Phase 1Completed
- Sponsor
- Future University in Egypt
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ciprofloxacin in bacterial infection (2 arms), sponsored by Future University in Egypt. Primary endpoints: Maximum blood concentration, Area under the curve (AUC 0-t) and 1 more. Started Nov 2020; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05532267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05532267.